News & Updates

Show Multimedia Only
Cervical cancer screening: Which HPV test to choose?

Cervical cancer screening: Which HPV test to choose?

28 Aug 2022 byChristina Lau

Adding a high-risk human papillomavirus (HPV) test to cytology may enhance detection of high-grade cervical intraepithelial neoplasia (CIN) in primary cervical cancer screening, with the Cobas 4800 and Hybrid Capture 2 (HC2) tests showing comparable clinical performance in high-risk HPV detection in Chinese women, according to a large study by the University of Hong Kong.

28 Aug 2022
Live birth after breast cancer may improve overall survival

Live birth after breast cancer may improve overall survival

22 Aug 2022 byRoshini Claire Anthony

Women who become pregnant and have a live birth following a diagnosis of breast cancer may have better overall survival (OS) outcomes than those without live births post-cancer, according to a study presented at ESHRE 2022.

22 Aug 2022
Rise in late-stage cervical cancer in SG linked to suboptimal screening uptake

Rise in late-stage cervical cancer in SG linked to suboptimal screening uptake

22 Aug 2022 byJairia Dela Cruz

Local researchers note a rising trend of late-stage cervical cancer in Singapore, a pattern that they say is likely to be an effect of a less than optimal uptake of screening for the disease.

22 Aug 2022